Manuel Rosa-Calatrava
8Patents
2h-index
18Co-inventors
40Inventor score
Filing activity: Dec 7, 2010 → Jul 12, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9433592B2 | Pharmaceutical or veterinary antiviral compositions | Human Necessities | 4 | Active |
| US9381238B2 | Method for improving the production of influenza viruses and vaccine seeds | Chemistry; Metallurgy | 3 | Active |
| US11351180B2 | Antiviral compositions for treating the flu | Human Necessities | 1 | Active |
| US8956626B2 | Modified viral strains and method for improving the production of vaccine seeds of influenza virus | Chemistry; Metallurgy | 1 | Active |
| US10144917B2 | Method for preparing a vaccine antigen, resulting vaccine antigen and uses | Chemistry; Metallurgy | 1 | Active |
| US11504424B2 | Attenuated virus strain and use thereof as a vaccine | Chemistry; Metallurgy | 0 | Active |
| US12285433B2 | Diltiazem for use in the treatment of microbial infections | Human Necessities | 0 | Active |
| US11510896B2 | Antiviral compositions for the treatment of infections linked to coronaviruses | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.